Clik here to view.
How long does it take for new prescription drugs to become mainstream?
You probably don’t want to hear your doctor proclaiming “I’m so indie, I was prescribing that *way* before it was cool.” Or maybe you do? If you’re a hipster and you really need to know when a...
View ArticleClik here to view.
A trade to fall back on
There’s a scene from “The Vartabedian Conundrum” in Big Bang Theory where Sheldon says that his Aunt Marion gave him a stethoscope as a child because “he should have a trade to fall back on” if the...
View ArticleClik here to view.
How about a systematic review that writes itself?
Guy Tsafnat, me, Paul Glasziou and Enrico Coiera have written an editorial for the BMJ on the automation of systematic reviews. I helped a bit, but the clever analogy with the ticking machines from...
View ArticleClik here to view.
Neuropsych trials involving kids are designed differently when funded by the...
Over the short break that divided 2013 and 2014, we had a new study published looking at the designs of neuropsychiatric clinical trials that involve children. Because we study trial registrations and...
View ArticleClik here to view.
Should we ignore industry-funded research in clinical medicine?
A quick update to explain our most recent editorial [pdf] on evidence-based medicine published in the Journal of Comparative Effectiveness Research. It’s free for anyone to access. What do we know?...
View ArticleClik here to view.
How to predict the conclusion of a review without even reading it…
Short version: We published a new article in the Journal of Clinical Epidemiology all about selective citation in reviews of neuraminidase inhbitors – like Tamiflu and Relenza. Lots of reviews get...
View ArticleRepost: Pharma’s influence over published clinical evidence
Below is a copy of an article I wrote for The Conversation. It’s an independent source of information and analysis about things that matter - but from the university and research perspective, which...
View Article